This study sought to evaluate the feasibility, safety, and efficacy of the Ultraseal device for left atrial appendage closure (LAAC) (Cardia, Eagan, Minnesota) in patients with nonvalvular atrial fibrillation at high bleeding risk
Preliminary studies suggest that left atrial appendage (LAA) closure might be beneficial in the prev...
Background. Left atrial appendage closure (LAAC) using the LAmbre device has been associated with pr...
Atrial fibrillation (AF) is the most common arrhythmia. It is associated with substantial risk of co...
To assess feasibility and safety of second-generation left atrial appendage closure (LAAC) Ultraseal...
International audiencePercutaneous left atrial appendage (LAA) closure is an emerging option for pat...
Background: Percutaneous closure of the left atrial appendage (LAA) is a novel alternative for the t...
Atrial fibrillation (AF) is common and is a prominent risk factor for ischemic stroke. Oral anticoag...
OBJECTIVES: To evaluate patient selection, safety, feasibility, and midterm results of percutaneous ...
Percutaneous left atrial appendage closure (LAAC) has emerged as an alternative to oral anticoagulat...
Atrial fibrillation (AF) is the most common arrhythmia in the elderly population and it is associate...
Percutaneous left atrial appendage closure technology for stroke prevention in patients with atrial ...
Percutaneous left atrial appendage (LAA) closure can be an alternative to coumadin treatment in pati...
AbstractObjectivesTo evaluate patient selection, safety, feasibility, and midterm results of percuta...
ObjectivesThe aim of this study was to evaluate the results associated with left atrial appendage cl...
Background/ObjectiveAtrial fibrillation (AF) is the most common sustained cardiac arrhythmia. It is ...
Preliminary studies suggest that left atrial appendage (LAA) closure might be beneficial in the prev...
Background. Left atrial appendage closure (LAAC) using the LAmbre device has been associated with pr...
Atrial fibrillation (AF) is the most common arrhythmia. It is associated with substantial risk of co...
To assess feasibility and safety of second-generation left atrial appendage closure (LAAC) Ultraseal...
International audiencePercutaneous left atrial appendage (LAA) closure is an emerging option for pat...
Background: Percutaneous closure of the left atrial appendage (LAA) is a novel alternative for the t...
Atrial fibrillation (AF) is common and is a prominent risk factor for ischemic stroke. Oral anticoag...
OBJECTIVES: To evaluate patient selection, safety, feasibility, and midterm results of percutaneous ...
Percutaneous left atrial appendage closure (LAAC) has emerged as an alternative to oral anticoagulat...
Atrial fibrillation (AF) is the most common arrhythmia in the elderly population and it is associate...
Percutaneous left atrial appendage closure technology for stroke prevention in patients with atrial ...
Percutaneous left atrial appendage (LAA) closure can be an alternative to coumadin treatment in pati...
AbstractObjectivesTo evaluate patient selection, safety, feasibility, and midterm results of percuta...
ObjectivesThe aim of this study was to evaluate the results associated with left atrial appendage cl...
Background/ObjectiveAtrial fibrillation (AF) is the most common sustained cardiac arrhythmia. It is ...
Preliminary studies suggest that left atrial appendage (LAA) closure might be beneficial in the prev...
Background. Left atrial appendage closure (LAAC) using the LAmbre device has been associated with pr...
Atrial fibrillation (AF) is the most common arrhythmia. It is associated with substantial risk of co...